Article Text

other Versions

PDF
Contribution of PTEN large rearrangements in Cowden disease: a MAPH screening approach.
  1. Frederic Chibon (chibon{at}bergonie.org)
  1. Laboratoire de Genetique Moleculaire, Institut Bergonie, Bordeaux, France
    1. Charlotte Primois (primois.charlotte{at}modulonet.fr)
    1. Laboratoire de Genetique Moleculaire, Institut Bergonie, Bordeaux, France
      1. Jean-Marc Bressieux (jmarc.bressieux{at}ch-troyes.fr)
      1. Service de Dermatologie, Centre Hospitalier, Troyes, France
        1. Didier Lacombe (didier.lacombe{at}chu-bordeaux.fr)
        1. Service de Genetique Medicale,CHU et EA 3669, universite Victor Segalen-Bordeaux 2, Bordeaux, France
          1. Catherine Lok (lok.catherine{at}chu-amiens.fr)
          1. Service de Dermatologie, Centre Hospitalier Universitaire Sud, Amiens, France
            1. Louis Mauriac (mauriac{at}bergonie.org)
            1. Departement d'Oncologie medicale, Institut Bergonie, Bordeaux, France
              1. Alain Taieb (alain.taieb{at}chu-bordeaux.fr)
              1. Service de Dermatologie et de Dermatologie Pediatrique, Centre Hospitalier Universitaire, Bordeaux, France
                1. Michel Longy (longy{at}bergonie.org)
                1. Genetique Moleculaire, Institut Bergonie et EA 3669, Universite Victor Segalen-Bordeaux 2, Bordeaux, France

                  Abstract

                  Background: Cowden disease is an autosomal dominant syndrome predisposing to cancer and characterized by the occurrence throughout life of hyperplastic, hamartomatous and tumoral lesions affecting various organs. In 60% to 80% of patients a germline intragenic point mutation of the PTEN tumor suppressor gene is identified but at least 20% of patients with a well characterized phenotype remain without any identified mutation.

                  Methods: To evaluate the impact of large rearrangement involving the PTEN locus in Cowden disease, we analysed by a Multiplex Amplifiable Probe Hybridization (MAPH) technique 80 unrelated patients referred for diagnosed or suspected Cowden disease, and in whom no PTEN point mutation was detected by a denaturing gradient gel electrophoresis (DGGE) screening.

                  Results: Four heterozygous genomic deletions involving the PTEN gene were identified. These deletions ranged from 13.6 kb to 662 kb and are restricted to the PTEN locus in two cases. In the two other cases, the deletion encompassed PTEN and either two or three contiguous genes without any obvious phenotypic effect except a possible consequence of ATAD1 haplo-insufficiency on bone growth. Sequence analysis of the four deleted alleles did not reveal identity or sequence homology at the two breakpoints of a same allele, suggesting that a mechanism such as non-homologous recombination of the breakage and reunion type could lead to the occurrence of these deletions.

                  Conclusion: Large rearrangements of the PTEN gene can be involved as causing mutation in Cowden disease and MAPH is an efficient screening methodology to detect such a genetic alteration.

                  Statistics from Altmetric.com

                  Request permissions

                  If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.